Formulation for Inhibiting Formation of 5-HT2B Agonists and Methods of Using Same
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 5 of these applications claim priority to application 15/667,112, filed Aug 2, 2017. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,603,290 | Formulation for Inhibiting Formation of 5-HT2B Agonists and Methods of Using Same In force · Medium confidence | Zogenix International Limited | In force | Medium confidence | ||
| US 11,040,018 | Formulation for Inhibiting Formation of 5-HT2B Agonists and Methods of Using Same In force · Medium confidence | Zogenix International Limited | In force | Medium confidence | ||
| US 11,406,606 | Formulation for Inhibiting Formation of 5-HT2B Agonists and Methods of Using Same In force · Medium confidence | Zogenix International Limited | In force | Medium confidence | ||
| US 11,759,440 | Formulation for Inhibiting Formation of 5-HT2B Agonists and Methods of Using Same In force · Medium confidence | Zogenix International Limited | In force | Medium confidence | ||
| US 11,786,487 | Formulation for Inhibiting Formation of 5-HT2B Agonists and Methods of Using Same In force · Medium confidence | Zogenix International Limited | In force | Medium confidence | ||
| Application 15/667,112 | Formulation for Inhibiting Formation of 5-HT2B Agonists and Methods of Using Same Abandoned Abandoned Nov 20, 2019 | Zogenix International Limited | Abandoned | Abandoned Nov 20, 2019 |
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
5 of these are in force and held by Zogenix, Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.